XML 28 R7.htm IDEA: XBRL DOCUMENT v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Consolidated net loss $ (663) $ (754)
Adjustments to reconcile consolidated net loss to net cash and cash equivalents provided by operating activities:    
Depreciation and amortization expense 193 163
Stock-based compensation expense 855 831
Operating lease non-cash expense 102 88
Accretion on marketable securities, net (33) (50)
Other adjustments (15) 3
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable 410 (22)
Prepaid expenses and other current assets (38) (21)
Deferred cost of revenue (23) (208)
Other assets 0 (6)
Accounts payable (23) 20
Accrued expenses and other current liabilities 170 37
Developer exchange liability (52) 53
Deferred revenue 533 1,112
Operating lease liabilities (109) (84)
Other long-term liabilities 35 27
Net cash and cash equivalents provided by operating activities 1,342 1,189
Cash flows from investing activities:    
Acquisition of property and equipment (83) (143)
Purchases of intangible assets (5) (1)
Payments related to business combinations, net of cash acquired (6) 0
Purchases of investments (3,887) (4,072)
Maturities of investments 2,181 2,669
Sales of investments 873 574
Other investing activities 4 0
Net cash and cash equivalents used in investing activities (923) (973)
Cash flows from financing activities:    
Proceeds from issuance of common stock 45 85
Repurchases of common stock (576) 0
Net cash and cash equivalents provided by (used in) financing activities (531) 85
Effect of exchange rate changes on cash and cash equivalents 0 4
Net increase/(decrease) in cash and cash equivalents (112) 305
Cash and cash equivalents    
Beginning of period 1,205 712
End of period 1,093 1,017
Supplemental disclosure of noncash investing and financing activities:    
Property and equipment additions in accounts payable, accrued expenses and other current liabilities, and other long-term liabilities 125 48
Repurchases of common stock included in accrued liabilities $ 4 $ 0